Is Moderna listed on the ASX? The vaccine company has become a household name over the past two years. Moderna vaccines were approved for use against COVID-19 back in August last year. Since then, countless doses have been put in arms across the country.
What's more, we got the news today that the Federal Government and the Victorian Government has partnered up with Moderna to build the first mRNA vaccine manufacturing hub in the Southern Hemisphere.
According to reporting from the ABC, the two governments will provide support for Moderna to construct a manufacturing facility in Victoria. The exact location is yet to be determined. According to the report, all parties are hoping that the new plant will produce its first vaccines "sometime in 2024". But the facility will not be restricted to just COVID vaccines. There are "plans to develop a number of other respiratory treatments and vaccines" too. These are likely to include influenza (the flu) and respiratory syncytial virus.
So now Moderna is set to have such a strong presence in Australia, many investors might be hoping to get a piece of the action in their own portfolios. So is Moderna an ASX listed share?
Are Moderna shares on the ASX?
Unfortunately, the answer is no.
Moderna is indeed a public company. But it is an American one through and through, having been founded in Massachusetts in 2010. As such, Moderna shares are listed on the US markets. Specifically, the company is on the Nasdaq exchange. Its full name is Moderna Inc (NASDAQ: MRNA). That's a highly applicable ticker code if there ever was one.
So unfortunately for ASX investors, we can't buy Moderna shares directly on the ASX. If you wanted to buy the company's shares, you would need to do so by buying the US-listed shares through a supporting broker.
Alternatively, Moderna is a constituent of both the S&P 500 Index (INDEXSP: .INX) and the NASDAQ-100 Index (NASDAQ: NDX). Both of these indexes have ASX exchange-traded funds (ETFs) that track them. So that is another avenue to explore for any aspiring Moderna investors.
But, as is the case with many global companies, there just isn't a direct ASX listing for us Aussies to go with.
The Moderna share price is currently up by 35.8% over the past 12 months, although it has taken a 24% haircut in 2022 so far. At the last Moderna share price of US$178.73, the company had a market capitalisation of US$72.03 billion.
